Mitt Romney, the former Republican presidential nominee, recently underwent surgery to remove his prostate after being diagnosed with prostate cancer in 2017. According to the American Cancer Society, he joined the 161,360 other men diagnosed with the cancer in 2017 with a number expected to jump to 164,690 in 2018. Romey is expected to run for US Senate for Utah soon.
According to the world-renowned urologist and oncologist Dr. David Samadi, his prognosis is great thanks to his decision to have surgery instead of going with radiation. Dr. David Samadi specializes in the diagnoses and treatment of prostate cancer as the Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital. The frequent Fox News contributor has performed around 7,000 robotic-assisted surgeries. Before serving at Lenox Hill, Samadi was the Vice Chair of Urology at Mount Sinai Medical Center. When he made the move to Lenox Hill in 2013, he took his entire operating team from Mount Sinai with him.
Prostate cancer patients who choose surgery over radiation have a much better chance of survival. Men who choose radiation are 1.5 times more likely to die than their counterparts who chose surgery and they’re twice as likely to die. The damage from the radiation is likely to cause secondary cancer which makes the chances of living longer than 5 years after receiving a diagnosis of cancer outside the prostate less than 30%. According to Samadi, if a patient has their prostate removed after the cancer is localized, there is a nearly 100% survival rate after surgery.
Dr. David Samadi earned his B.S. and M.D. at Stony Brook University and Stony Brook University Medical Center. Samadi received postdoctorate training in proctology and urology through the Albert Einstein College of Medicine and Montefiore Medical Center. A fellowship in proctology was completed through Memorial Sloan Kettering Cancer Center with an additional fellowship in robotic prostateectomy at Henri Mondor Creteil in 2002. His fellowship at Mondor Creteil was in France under the mentorship of Claude.
Samadi is an Iranian immigrant who immigrated out of the country after the Iranian Revolution at the age of 15. Samadi moved with his brother initially to London and Belgium before completing their education in the United States. Samadi believes his experiences in the Iranian Revolution helps him empathize with his patients.
Dr. David Samadi’s Social Media: www.youtube.com/user/RoboticOncology